These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 35096274)

  • 1. The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response.
    He S; Xu J; Wu J
    Oxid Med Cell Longev; 2022; 2022():8796735. PubMed ID: 35096274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress drives CD8
    Li S; Zhu G; Yang Y; Jian Z; Guo S; Dai W; Shi Q; Ge R; Ma J; Liu L; Li K; Luan Q; Wang G; Gao T; Li C
    J Allergy Clin Immunol; 2017 Jul; 140(1):177-189.e9. PubMed ID: 27826097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research progress of vitiligo repigmentation: from oxidative stress to autoimmunity.
    Yu T; Wu Y; Lu Z
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):147-151. PubMed ID: 38678613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitexin protects melanocytes from oxidative stress via activating MAPK-Nrf2/ARE pathway.
    Li XS; Tang XY; Su W; Li X
    Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):594-603. PubMed ID: 33045867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications.
    Chang WL; Ko CH
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis.
    Li D; Liang G; Calderone R; Bellanti JA
    Med Hypotheses; 2019 Jul; 128():69-75. PubMed ID: 31203913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphenols targeting multiple molecular targets and pathways for the treatment of vitiligo.
    Yang Y; Du Y; Cui B
    Front Immunol; 2024; 15():1387329. PubMed ID: 39119340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death.
    Xuan Y; Yang Y; Xiang L; Zhang C
    Oxid Med Cell Longev; 2022; 2022():8498472. PubMed ID: 35103096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-P2X7-Induced Inflammasome Activation Contributes to Melanocyte Death and CD8
    Ahn Y; Seo J; Lee EJ; Kim JY; Park MY; Hwang S; Almurayshid A; Lim BJ; Yu JW; Oh SH
    J Invest Dermatol; 2020 Sep; 140(9):1794-1804.e4. PubMed ID: 32035094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection.
    Xie B; Zhu Y; Shen Y; Xu W; Song X
    Expert Opin Ther Targets; 2023 Mar; 27(3):189-206. PubMed ID: 36947026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin.
    Barygina V; Becatti M; Lotti T; Moretti S; Taddei N; Fiorillo C
    J Dermatol Sci; 2015 Aug; 79(2):163-70. PubMed ID: 26051876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review.
    Białczyk A; Wełniak A; Kamińska B; Czajkowski R
    Mol Diagn Ther; 2023 Nov; 27(6):723-739. PubMed ID: 37737953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes.
    Qiao Z; Wang X; Xiang L; Zhang C
    Oxid Med Cell Longev; 2016; 2016():3401570. PubMed ID: 28018522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in understanding vitiligo.
    Manga P; Elbuluk N; Orlow SJ
    F1000Res; 2016; 5():. PubMed ID: 27635239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.